Useful information
Prime News delivers timely, accurate news and insights on global events, politics, business, and technology
Paperplane therapy He has raised $ 1.5 million to treat patients for pain and anxiety using virtual reality, possibly make the dentist trips more pleasant.
The company based in Montreal, Canada, is specified in virtual reality therapeutic solutions for pain management and anxiety in medical care.
Glen Ventures led the round, with the financial support of the Gouvernement Du Québec through Investissement Québec. Strategic investors such as Cabhi (Center for Aging + Brain Health Innovation), the Cedars-Sinai intellectual property company, Anges Québec and Capital Aventure.
Pain and anxiety represent important barriers to patients seeking medical care, often lead to more complex delays and treatments. This problem is particularly frequent in dentistry, where approximately 36% of people experience anxiety during dental visits, 12% suffer from extreme dental fear and 22% postpone appointments until pain forces them to seek attention, which, which results in higher costs and complications.
With this in mind, Paperplane is focusing on the North America dental market, with the aim of improving the experiences of patients and clinical workflows through their virtual reality therapeutic solutions.
Paperplane’s technology addresses this challenge by transforming dental procedures, often perceived as painful and traumatic, into more manageable, even pleasant experiences through immersive virtual reality.
Designed for patients of all ages, with a particular emphasis on pediatric care, Paperplane solutions help make patients more comfortable. Paperplane also speeds up clinical workflows and reduces load on doctors.
“As an emergency doctor, I have seen firsthand the lack of options available to handle pain and anxiety,” said Jean-Simon Fortin, CEO of Paperplane Therapeutics, in a statement. “Today, I am proud to see that our virtual reality technology fills that void, providing health professionals with a more effective way to support their patients. This financing will allow us to expand our reach, allowing even more doctors to provide truly transformative attention. “
This financing marks a significant milestone in the growth of Paperplane and will allow the company to continue its mission of deploying virtual reality therapies in the dental sector, improving both the results of the patients and the provision of care in North America. In addition, this investment will support Paperplane’s expansion in Europe through a strategic association with the French company Hypnovr, backed by its CE Mark certification.
Michael Goodman, founding partner of Glen Ventures, said in a statement: “Paperplane is redefining how we address pain management and anxiety in medical care. Their virtual reality solutions not only improve the patient’s comfort, but also contribute to more efficient clinical workflows. We are proud to support a company that is increasing the standard of patient care while pushing the limits of medical innovation. “
Christopher Skeete, Minister of Economy and Minister of Quebec, responsible for the fight against racism, said in a statement: “Quebec’s ingenuity has the power to shape the future of our health system, and Paperplane’s therapy Excellent example. Our government is proud to support the development of solutions that improve both quality and accessibility of patient care. “
“Paperplane Therapeutics is helping to place Quebec as a leader in medical technology innovation through its virtual reality solutions,” added Bicha NGO, CEO of Investissement Québec, in a statement. “By rethinking the patient’s experience, the company demonstrates the immense potential of the Quebec health innovation ecosystem. With this investment, they now have the resources to accelerate their growth. “
